• August 6, 2014  

    The treatment of two Ebola-infected Americans with an experimental drug, Z-Mapp, raises the question of whether it has potential for widespread use in combating the outbreak in West Africa. Judy Woodruff gets perspective on the topic from two experts, Dr. Robert Garry of Tulane University School of Medicine and Laurie Garrett of the Council on Foreign Relations. Continue reading